Png, M., Harris, V., Grabey, J., Hart, N., Jani, B., Butler, D., . . . Collaborators, . P. T. (2024). Cost-utility analysis of molnupiravir plus usual care versus usual care alone as early treatment for community-based adults with COVID-19 and increased risk of adverse outcomes in the UK PANORAMIC trial. Royal College of General Practitioners.
Chicago Style (17th ed.) CitationPng, ME, et al. Cost-utility Analysis of Molnupiravir Plus Usual Care Versus Usual Care Alone as Early Treatment for Community-based Adults with COVID-19 and Increased Risk of Adverse Outcomes in the UK PANORAMIC Trial. Royal College of General Practitioners, 2024.
MLA (9th ed.) CitationPng, ME, et al. Cost-utility Analysis of Molnupiravir Plus Usual Care Versus Usual Care Alone as Early Treatment for Community-based Adults with COVID-19 and Increased Risk of Adverse Outcomes in the UK PANORAMIC Trial. Royal College of General Practitioners, 2024.